Save your place

Sign in to WhoBought

Please try again later.

Altimmune, Inc. (ALT) institutional ownership

Latest close $2.77 Jul 24, 2026
Market cap$334M 52-week range SectorHealthcare
Funds holding · Q1 2026
174
reported ALT position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Net bought $61M
106 buyers · 68 sellers

Altimmune, Inc. (ALT) price and institutional activity

Dates

Q1 2026

$103M bought by 106 investors
Marshall Wace, LLP$13MBlackRock$13M +104 more
$41M sold by 68 investors
Jane Street Group, LLC-$7.6MTang Capital Management LLC-$6.2M +66 more
Bought Sold Totals per quarter; hover a bar for the names.

Altimmune, Inc. (ALT) institutional activity · 174

Investor Type Est. change Change Δ Own Date
Marshall Wace, LLP · Added +$13M
Change +3.1M Date Q1 2026
Marshall Wace, LLP Added· Q1 2026 +$13M +3.1M Q1 2026
BlackRock · Added +$13M
Change +3.1M Date Q1 2026
BlackRock Added· Q1 2026 +$13M +3.1M Q1 2026
Millennium Management LLC · Added +$13M
Change +3.1M Date Q1 2026
Millennium Management LLC Added· Q1 2026 +$13M +3.1M Q1 2026
Alyeska Investment Group, L.P. · New +$11M
Change +2.6M Date Q1 2026
Alyeska Investment Group, L.P. New· Q1 2026 +$11M +2.6M Q1 2026
Vanguard · Added +$10M
Change +2.5M Date Q1 2026
Vanguard Added· Q1 2026 +$10M +2.5M Q1 2026
State Street · Added +$8.6M
Change +2.0M Date Q1 2026
State Street Added· Q1 2026 +$8.6M +2.0M Q1 2026
Jane Street Group, LLC · Exited −$7.6M
Change −1.8M Δ Own −100.0% Date Q1 2026
Jane Street Group, LLC Exited· Q1 2026 −$7.6M −1.8M −100.0% Q1 2026
Tang Capital Management LLC · Reduced −$6.2M
Change −1.5M Date Q1 2026
Tang Capital Management LLC Reduced· Q1 2026 −$6.2M −1.5M Q1 2026
Two Sigma Investments, LP · Added +$5.2M
Change +1.2M Δ Own +95.9% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +$5.2M +1.2M +95.9% Q1 2026
Nuveen, LLC · Added +$4.6M
Change +1.1M Date Q1 2026
Nuveen, LLC Added· Q1 2026 +$4.6M +1.1M Q1 2026
Knoll Capital Management, LLC · Reduced −$4.1M
Change −962K Date Q1 2026
Knoll Capital Management, LLC Reduced· Q1 2026 −$4.1M −962K Q1 2026
Citadel Advisors LLC Reduced· Q1 2026 −$3.8M −889K −66.5% Q1 2026
Geode · Added +$3.5M
Change +815K Date Q1 2026
Geode Added· Q1 2026 +$3.5M +815K Q1 2026
Two Sigma Advisers, LP · Exited −$3.4M
Change −794K Δ Own −100.0% Date Q1 2026
Two Sigma Advisers, LP Exited· Q1 2026 −$3.4M −794K −100.0% Q1 2026
Dimensional · Added +$3.2M
Change +762K Date Q1 2026
Dimensional Added· Q1 2026 +$3.2M +762K Q1 2026
Data through Q1 2026 · filed Jun 3, 2026
15 of 174

Famous investor activity in Altimmune, Inc. (ALT)

Altimmune, Inc. (ALT) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Lawver Teri L. · Director Grant (A) 49K
Owned 49K Trade date May 1, 2026 Filed date May 1, 2026
Lawver Teri L. Director Grant (A) 49K 49K May 1, 2026 May 1, 2026
Sohn Catherine A. · Director Grant (A) 49K
Owned 49K Trade date May 1, 2026 Filed date May 1, 2026
Sohn Catherine A. Director Grant (A) 49K 49K May 1, 2026 May 1, 2026
Jorkasky Diane · Director Grant (A) 49K
Owned 49K Trade date May 1, 2026 Filed date May 1, 2026
Jorkasky Diane Director Grant (A) 49K 49K May 1, 2026 May 1, 2026
Schafer Klaus · Director Grant (A) 49K
Owned 49K Trade date May 1, 2026 Filed date May 1, 2026
Schafer Klaus Director Grant (A) 49K 49K May 1, 2026 May 1, 2026
Pisano Wayne · Director Grant (A) 49K
Owned 49K Trade date May 1, 2026 Filed date May 1, 2026
Pisano Wayne Director Grant (A) 49K 49K May 1, 2026 May 1, 2026
Hodges Philip · Director Grant (A) 49K
Owned 49K Trade date May 1, 2026 Filed date May 1, 2026
Hodges Philip Director Grant (A) 49K 49K May 1, 2026 May 1, 2026
Gill John · Director Grant (A) 49K
Owned 49K Trade date May 1, 2026 Filed date May 1, 2026
Gill John Director Grant (A) 49K 49K May 1, 2026 May 1, 2026
Sayare Mitchel · Director Grant (A) 49K
Owned 49K Trade date May 1, 2026 Filed date May 1, 2026
Sayare Mitchel Director Grant (A) 49K 49K May 1, 2026 May 1, 2026
Gill John · Director Buy +$31K
Price $3.41 Qty +9K Owned 22K Trade date Apr 6, 2026 Filed date Apr 6, 2026
Gill John Director Buy $3.41 +9K +$31K 22K Apr 6, 2026 Apr 6, 2026
Weaver Gregory L. · CFO Buy +$31K
Price $3.15 Qty +10K Owned 38K Trade date Apr 1, 2026 Filed date Apr 1, 2026
Weaver Gregory L. CFO Buy $3.15 +10K +$31K 38K Apr 1, 2026 Apr 1, 2026
Durso Jerome Benedict · Director Buy +$47K
Price $3.14 Qty +15K Owned 48K Trade date Apr 1, 2026 Filed date Apr 1, 2026
Durso Jerome Benedict Director Buy $3.14 +15K +$47K 48K Apr 1, 2026 Apr 1, 2026
Weaver Gregory L. · Officer Buy +$18K
Price $3.54 Qty +5K Owned 28K Trade date Mar 6, 2026 Filed date Mar 9, 2026
Weaver Gregory L. Officer Buy $3.54 +5K +$18K 28K Mar 6, 2026 Mar 9, 2026
Durso Jerome Benedict · Director, Officer Buy +$71K
Price $3.54 Qty +20K Owned 32K Trade date Mar 6, 2026 Filed date Mar 9, 2026
Durso Jerome Benedict Director, Officer Buy $3.54 +20K +$71K 32K Mar 6, 2026 Mar 9, 2026
Roberts M. Scot · Officer 2 operations 318K
Owned 95K Trade date Feb 26, 2026 Filed date Feb 27, 2026
Roberts M. Scot Officer 2 operations 318K 95K Feb 26, 2026 Feb 27, 2026
Weaver Gregory L. · Officer 2 operations 370K
Owned 111K Trade date Feb 26, 2026 Filed date Feb 27, 2026
Weaver Gregory L. Officer 2 operations 370K 111K Feb 26, 2026 Feb 27, 2026
15 of 61
15 of 61 Sign in to continue to older insider transactions.

Altimmune, Inc. (ALT) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Deep Track Capital, LP 19.4M
% of shares outstanding 10.0% Filing date Apr 30, 2026
Deep Track Capital, LP 19.4M 10.0% Apr 30, 2026
BlackRock Inc. 4.0M
% of shares outstanding 7.5% Filing date Jan 26, 2024
BlackRock Inc. 4.0M 7.5% Jan 26, 2024
Viking Global Investors LP 13.4M
% of shares outstanding 6.7% Filing date May 1, 2026
Viking Global Investors LP 13.4M 6.7% May 1, 2026
Vanguard Group Inc 3.6M
% of shares outstanding 6.7% Filing date Feb 13, 2024
Vanguard Group Inc 3.6M 6.7% Feb 13, 2024
Ra Capital Management, L.P. 13.0M
% of shares outstanding 6.5% Filing date May 1, 2026
Ra Capital Management, L.P. 13.0M 6.5% May 1, 2026
State Street Corp 7.1M
% of shares outstanding 5.5% Filing date May 12, 2026
State Street Corp 7.1M 5.5% May 12, 2026
Ameriprise Financial Inc 3.9M
% of shares outstanding 5.5% Filing date Nov 14, 2024
Ameriprise Financial Inc 3.9M 5.5% Nov 14, 2024
Cormorant Asset Management, LP 2.6M
% of shares outstanding 5.3% Filing date Feb 14, 2023
Cormorant Asset Management, LP 2.6M 5.3% Feb 14, 2023
8 of 18

Altimmune, Inc. (ALT) ownership FAQ

Who owns ALT?

174 reporting institutions disclosed ALT position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.